FDA Recalls Finder

FDA Announces Draft Revised Guidance on Transparency and Advisory Committees
21 April 2010, 10:00 am

The U.S. Food and Drug Administration today announced draft guidance that would expand transparency and disclosure when the agency grants a conflict of interest waiver to permit an individual’s participation at an FDA advisory committee meeting.

Source: Food and Drug Administration--Press Releases